Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:54 AM
Ignite Modification Date:
2025-12-25 @ 12:54 AM
NCT ID:
NCT07269067
Eligibility Criteria:
Inclusion Criteria:
* Confirmed diagnosis of acute myeloid leukaemia per ELN 2022
* Age ≥ 18 years (adult cohort) or 0-20 years (paediatric cohort)
* Inclusion in DATAML Bordeaux database or paediatric haemato-oncology records
* Available flow-cytometry MRD data post-induction and post-consolidation 1
* Non-opposition or consent for secondary use of data
Exclusion Criteria:
* AML subtypes M3, M6 or M7
* Acute leukaemia of ambiguous lineage
* Missing or unusable flow-cytometry files for required time points
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT07269067
Study Brief:
Protocol Section:
NCT07269067